Investors

In 2025, the hair loss market is expected to top US$12 billion. More than ever, people are concerned about their looks, lifestyle and general health.

98%

Rogaine and versions of private label Minoxidil control 98% of the topical hair growth market in the U.S.

40 years

No new FDA-approved drug has been marketed in the last 40 years.

$2 560

Average spent for hair loss products in the US per patient, per year.

Looking to invest?

    Recent publications
    CORPORATE NEWS
    READ MORE
    Triple Hair
    Corporate
    Triple Hair Wins “Jury’s Choice Award” at Octane Aesthetic Tech Forum
    READ MORE
    Triple Hair
    Corporate
    Triple Hair Group Signs Licensing Agreement for South Korean Market with Mother’s Pharmaceutical
    READ MORE
    Triple Hair
    Corporate
    OpportunitiesNB Article on an interview with our CEO Jean-Phillipe Gravel